Joel Batts, MA – Strategic Planning and Execution
Joel is a medical device industry veteran, with 20 years of leadership experience developing scientific and regulatory strategies for start-ups to large cap companies. He has delivered >$100 million return on investment by delivering FDA approvals for Class II and Class III devices in the musculoskeletal and wound care spaces. He has published and presented the results of pre-clinical and clinical science in journals such as American Journal of Sports Medicine, American Journal of Orthopaedics, and venues such as the American College of Foot and Ankle Surgeons. In 2010, he led a business development team in the application of a novel biologic material to osteoporotic patients for reducing the incidence of hip fractures. After conducting early-phase trials and developing the scientific and regulatory strategy, the team sold the technology for $30 million. He has also overseen key areas of investment and integration for four major acquisitions. Joel’s interests include the transformation of healthcare in developing countries of Africa, in partnership with the vision of LifeNet International. Joel earned a BS in exercise science from the University of Florida and an MA in bioethics and health policy from Loyola University Chicago Stritch School of Medicine.
Cassandra Latimer, MS – Client Science and Innovation Programs
Cassandra is a medical device and semiconductor industry entrepreneur and scientist, specializing in product development from bench to bedside. She understands what it takes to develop a product, and, more importantly, the need to show the benefits of the product through research. Cassandra has a long-standing reputation within the medical/scientific community for helping clients identify clinical requirements and conceptualize needs into prototypes and new products. With a specialty in analyses, statistics and publication planning, she is often sought after for her well established clinical expertise within spine, orthopedics, thoracic, colorectal, gynecology and ENT. Throughout the past 12 years, she has led scientific teams, and R&D efforts in the development of new products and regulatory clearance of expanded indications through preclinical experimentation and execution of clinical trials (Zimmer Biomet, Covidien). This includes extensive experience with IP generation based on identifying solutions for unmet clinical needs. This entrepreneurial work has resulted in a patent for an electrical surgical device, as well as 4 pending patents for various surgical devices. Cassandra’s academic accomplishments include a B.S. in Chemical Engineering from Arizona State University, and an M.S. in Chemical and Biomolecular Engineering from Colorado State University.
Kurt Burgess – Operations and Business Development
Kurt is a seasoned business development specialist with over 20 years of experience in driving business initiatives for small, mid-cap and enterprise corporations. Kurt’s work history includes key senior management positions with CAS Systems (acquired), Rainmaker Systems, and Hilton Hotels. His entrepreneurial experience includes independent consulting with the San Francisco Police Academy, a role as Executive Producer working with Grammy award- winning recording artists, and managing partner in a sports sponsorship effort for emerging junior elite athletes. Much of his free time is spent as a Montana Ambassador, working directly with Governor Bullock’s Office of Business and Economic Development. His Ambassador work has developed key strategic relationships uncovering synergistic economic development opportunities between CA-based corporations and the state of Montana; these relationships led to the launch of Injection Technologies, a medical device start-up currently considering strategic collaborations with a number of southern California based device firms.